Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05652725

Radicle Clarity: A Study of Health and Wellness Products on Mental Clarity and Health Outcomes

Conditions: Cognitive Function

Sex: All
Ages: 21 Years – 105 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 300
Sponsor: Radicle Science

Location: United States

Summary

A randomized, blinded, placebo-controlled direct-to-consumer study of health and wellness products on mental clarity and other health outcomes

Eligibility Criteria

Inclusion Criteria:Adults, 21 years of age and older at the time of electronic consent, inclusive of all ethnicities, races, genders and/or gender identitiesResides in the United StatesEndorses better concentration as a primary desireSelects concentration and/or looking to improve their concentration as a reason for their interest in taking a health and wellness productExpresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the studyExclusion Criteria:Reports being pregnant, trying to become pregnant, or breastfeedingUnable to provide a valid US shipping address and mobile phone numberThe calculated validated health survey (PRO) score during enrollment represents less than mild impairment or severityReports a diagnosis of liver or kidney diseaseReports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)Unable to read and understand EnglishReports current enrollment in a clinical trialLack of reliable daily access to the internetReports current or recent (within 3 months) use of chemotherapy or immunotherapyReports taking medications with a known moderate or severe interaction with any of the active ingredients studied or a substantial safety risk: Anticoagulants, a medication that warns against grapefruit consumption, corticosteroids at doses greater than 5 mgs per day, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, or MAOIsReports a diagnosis of heart disease when a known contraindication exists for any of the active ingredients studied: NYHA Class III or IV congestive heart failure, Atrial fibrillation, Uncontrolled arrhythmias

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05652725). StuddyBuddy aggregates publicly available trial information.